HC Wainwright & Co. initiated coverage on Salarius Pharmaceuticals with a new price target

8/25/21 6:10:11 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

HC Wainwright & Co. initiated coverage of Salarius Pharmaceuticals with a rating of Buy and set a new price target of $5.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$SLRX

Date	Price Target	Rating	Analyst
3/11/2022	$5.00 → $4.00	Buy	HC Wainwright & Co.
8/25/2021	$5.00	Buy	HC Wainwright & Co.